chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient had her MMR and Chickenpox vaccine on October 5-07 and had a slight fever October 7-07. The day of the 7th she was taking a nap and I found her having a seizue and had vomited. She was taken by ambulance to Hospital where she spent 3 days of MRI's, a CT scan and an EEG. No reason for the seizure was found! I did a little reseach of my own and found that the vaccines has seizure side effects!   10/30/07 Reviewed pcp medical records including vax records.  VAERS database updated w/same.  Records indicate patient in good health on 10/5/07 except for right hip contact dermtatitis.  Hospital d/c summary also included which indicates patient had vomited & was twitching w/head fixed to right when awakening from nap.  Taken to outlying hospital & transferred to higher level of care.  admitted 10/7-10/9/2007 w/final dx seizure.  Neuro consult done who dx as right sided complex partial seizure.  Return to pcp on 10/12    11/6/07 Received additional pcp records which reveal patient experienced seizure activity at home w/emesis.  MRI at that time revealed anomaly.  Admitted 10/7-10/09/2007.   FINAL DX: Seizure.
Patient had sudden cardiac arrest and had CPR from onset, was picked up by EMS and transported to hospital and pronounced dead at approx 11:30 PM.  12/16/09 Report of death received for 11/03/09.  Decedent fell on the floor while in a social gathering.  No pulse, CPR performed by school nurse for 10 mins until EMS came. Decedent had emesis while compressions were performed. EMS started ACLS, intubation, 3 IV lines, 4 Epi, 3 Atropine and 1 amp Bicarb. Sinus rhythm established 1 time, but lost. CPR unsuccessful. Decendent pronounced dead.   12/16/09 Autopsy results revealed no visible internal signs of trauma. All systems autopsy: normal. Teeth in poor condition. Cardiovascular system: myocardium: focal areas of fibrosis, atrial; bulges in atrial and ventricular muscular fee walls, interventricular septum 3cm thick. Pathologist opinion: Hypertrophic cardiomyopathy (790gr). Heart severely congested and lungs heavy with possible aspiration.  12/24/09 Toxicology report received. This report showed that no drugs were used.  01/04/09 Medical/dental record received for DOS 10/29/09. Debridement performed. Anesthesia used. Moderate to heavy generalized bleeding. Tx: Chlorhexidine gluconate oral rinse. DX: Gingivitis, periodontal disease.
Fever of 101.5 with shaking chills, sweats, headache, body aches started  2/1 at 9:45pm.  Nausea, with vomiting every 15 minutes started at  11:50pm through 2:30am on 2/2/2021.  Very dizzy and fainted on the bathroom floor at 12:15 am 2/2.  Dizziness, fever, headache, body aches and chills continued through entire day 2/2 . Fever through the night with sweating 2/3. Continue now with some fatigue.  Was unable to work 2/2 or 2/3 due to symptoms.
Within five hours of injection, redness and rash developed close to injection site.  Injection was at 4 pm on 3/18/21.  By the next morning, red, hot, swollen circular rash had formed about an inch from injection site, and several inches wide.  Today, rash is still painful, hot and growing (three days from injection).
Received Shingles Vaccine Zostavax. By evening had flu symptoms, sore throat and bronchitis. Have been sick for 10 since. Zostavax is made by Merc it looks like. Field 13 below will not let me type that in.
I thought I had strep throat as sore as my throat was; later, my symptoms developed into congestion and body aches. I tried to go in for testing for throat cultures, but my doctor's office told me I needed to test negative for COVID-19. On 01/16/2023, I took a home test which came back positive and startled me. They offered to prescribe me antivirals which I declined. I stayed home, rested and recovered in about two weeks after resting. I was still able to do my normal activities with slight lethargic.
Patient became pale & diaphoretic, drowsy but responsive   2 minutes total time of episode
Pt presents to clinic for flu vaccine. Following vaccine at approx 2 pm pt reports clamminess, "hot" and dizzy. BP 135/73 P51 O2 99% T 96.9 . Dr. assessed pt, ordered glucose check. BS 52 mg/dl. Pt alert and oriented. Recheck of BS was 48 mg/dl. Pt reports only had coffee today. Pt given fruit juice and cereal bar. BS recheck @2:22 82 mg/dl.
no adverse event; patient was inadvertently administered a dose of VARIVAX that had been improperly stored; This spontaneous report was received from a practice manager (also reported as administrator) and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant medications or medical history provided. On 10-MAR-2020, the patient was inadvertently administered an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) injection, lot # S021322, expiration date 09-JUL-2021 (formulation, strength, exact dose, route of administration were not provided) for prophylaxis. The vaccine was exposed to -8.3 degrees Celsius for 24 minutes. No additional adverse event was reported. Digital data logger was involved.
Received vaccine on 12/22/20, felt soreness at site with fatigue.  12/23/20 rash to right breast, 12/24/20 rash to left breast, 12/25/20 rash to abdomen, 12/26/20 rash to back, 12/28 rash to right thigh.  Rash to entire chest, abdomen, back and thigh still present. Started 12/28 Taking Benadryl and Hydrocortisone cream
4.5 hrs post vax pt cried approx 5 min; became red in face then pale in trunk & red & blue in LE; Pt was sitting w/mom remained "lifeless or limp x 30 min; Pt remained pale during this time;
Flu like symptoms; Headache; Fatigue; Fever; Joint pain; Muscle pain; Heaviness in chest; Heavy feeling; This case was reported by a physician via licensee and described the occurrence of influenza-like symptoms in a female patient who received Rabies NVS (RabAvert) for prophylaxis.   Concomitant products included Rabies NVS (RabAvert).   On 1st October 2020, the patient received the 2nd dose of RabAvert. On 1st October 2020, less than a day after receiving RabAvert, the patient experienced influenza-like symptoms, headache, fatigue, fever, joint pain, muscle pain, chest heaviness and sensation of heaviness. On an unknown date, the outcome of the influenza-like symptoms, headache, fatigue, fever, joint pain, muscle pain, chest heaviness and sensation of heaviness were recovered/resolved.   The reporter considered the influenza-like symptoms, headache, fatigue, fever, joint pain, muscle pain, chest heaviness and sensation of heaviness to be possibly related to RabAvert.  Additional details were provided as follows: The age at vaccination was not reported. The patient received pre-exposure vaccine series. The patient received 1st dose of RabAvert on 24th September 2020 and was fine. The patient received 2nd dose of vaccine and about 6-8 hours later she had flu like symptoms, headache, fatigue, fever, joint and muscle pain, heaviness in chest but later it was more like a heavy feeling all over. The patient had no chest pain, rashes, shortness of breath, cough, wheezes, upper respiratory symptoms (runny nose, congestion), abdominal pain, vomiting diarrhea, hives, closing throat/ airway. It sounded like side effects and not having a true anaphylactic reaction. The patient went to bed on the same evening and felt fine the next morning. The patient was also concerned enough to get a COVID test, but it came back negative. This case has been linked with US2020AMR208129 reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR208129:same reporter
Breakthrough case admission after 3 vaccines  Moderna 1/22/21 Lot# 011J20A;  Moderna 2/24/21 Lot# 023M20A;  Moderna 10/22/21 Lot# NO LOT NUMBER RECORDED
Information has been received from a male who in May 2008, was inadvertently vaccinated with a dose of GARDASIL vaccine (yeast) instead of hepatitis B for the third dose. No adverse experiences reported. No further information is available.
This spontaneous report was received from a Certified Medical Assistant (C.M.A.) regarding an unspecified number of patients of unknown ages and genders. The patients medical history or concurrent conditions were not provided. On an unspecified dates, the patients have been administered with a dose of RECOMBIVAX HB (dose, route, frequency, lot numbers and expiration dates were not provided), which have been exposed to temperatures outside of the recommended range. No adverse effect has been reported. This is one of several reports from the same source (MARRS #1507USA014064, 1507USA014065, 1507USA014066, 1507USA014068 and 1507USA013244). Additional information has been requested.
Febrile seizure w/questionable apnea episode, t103 had a rash on legs, back, hospitalized 18MAR to 20MAR92; mom stated no inc fever or s&s p/vax until 7 days post vax;
Shingles outbreak; rash across chest; blisters on chest; Impetigo; Nerve pain; postherpetic neuralgia; Lumbago with sciatica; Pityrosporum folliculitis; This case was reported by a lawyer and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) (batch number unk, expiry date unknown) for prophylaxis.   On an unknown date, the patient received Shingrix (intramuscular). On an unknown date, unknown after receiving Shingrix, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  The initial information was received on 10 December 2020 via medical record (case is now medically confirmed). The patient ingested 50 MCG shingrix injection from 02 October 2019. On 06 October 2019, patient had full blown shingles outbreak over the left chest area and near left scapular region. On 09 October 2019, patient had shingles was Zoster without complications, after taken vaccine 4 days later had pain and rash across chest area still with blisters. The patient had Impetigo. 07 November 2019 patient had Nerve pain from shingles, postherpetic neuralgia, Intercostal pain, Lumbago with sciatica, left side, Pityrosporum folliculitis.
Patient was diagnosed with covid infection on 5/16. He required inpatient admission,  but recovered quickly. Pulmonary function worsened after discharge, and he began hospice.
Patient received vaccine on 8-22 and had sore arm that evening. Then 8-23 developed some swelling and redness near elbow but nothing around injection site. She had a low grade fever and some soreness. All symptoms resolved by 8-24. No treatment was given.
Apparent case of varicella about 7 years after vaccination. Consisting of about 10 lesions.
Rash all over-spreading started as few on legs and arms. Seen in ER 6/26/04
This spontaneous report as received from a Registered Nurse concerning a patient of unknown age who on 29-MAR-2013 was vaccinated with a dose of PROQUAD that was exposed to unknown temperature conditions above 0 degrees C for 15 hours (Lot # H015789, Exp 24-FEB-2014) (dose and route not provided). No adverse symptoms reported. Additional information has been requested.
HPI: Noticed new bump just above clavicle's lateral edge. Denies trauma, injury, or any event to cause it. States received MMR booster in L arm SC on 11/20; states he tolerated well without any local reaction or swelling, erythema, or heat at injection site. Noticed deformity on 11/26. Denies pain, erythema, heat, edema, impeding ROM. EE state he has no PMH. Denies he's immunocompromised, recent infection or illness, fever, chills, night sweats, or unexplained weight loss.  EXAM: L SHOULDER/CLAVICLE: 1.5-2" in diameter fixed, raised mass above lateral edge of clavicle; rubbery to feel. Pigmentation same as surrounding skin. No erythema, heat, edema. No TTP. FROM of shoulder without discomfort. L ARM: small 0.5 cm bruise/erythema on posterior upper arm corresponding to SC injection. Flat. No heat and no TTP.  Evaluated in-person at WWC on 11/30. Referred to PCP, who diagnosed with supraclavicular lymphadenitis via telehealth visit 12/2. Will monitor and order US if no resolution or enlarges in next 3 months.
Hospitalization 8/21/21 for sepsis COVID19. Being treated with dexamethasone and Remdesivir
itch on back, arms, legs with pin pricks; itch on back, arms, legs with pin pricks; Headache; Fever; Pain; Nausea; This case was reported by a pharmacist via call center representative and described the occurrence of headache in a 72-year-old female patient who received Herpes zoster (Shingrix) (batch number 23LD9, expiry date 22nd April 2022) for prophylaxis.   On 1st February 2020, the patient received the 2nd dose of Shingrix. On 14th February 2020, 13 days after receiving Shingrix, the patient experienced pruritus and tingling skin. In February 2020, the patient experienced headache, fever, generalized aching and nausea. On an unknown date, the outcome of the headache was not recovered/not resolved and the outcome of the fever, generalized aching, nausea, pruritus and tingling skin were unknown.   It was unknown if the reporter considered the headache, fever, generalized aching, nausea, pruritus and tingling skin to be related to Shingrix.  Additional details were provided as follows: After receiving Shingrix, the patient developed headache, generalized pain , nausea and fever. The patient also developed an itch on back, arms, legs with pin pricks.
sore arm (injection site pain); headache; low-grade fever; severe joint pain; This is a spontaneous report from a contactable other hcp. A 22-year-old female non-pregnant patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: EK5730, Expiration Date: not reported), via an unspecified route of administration in left arm on 09Jan2021 10:00 as dose 2, single for COVID-19 immunization (at the age of 22-year-old). Patient historical vaccine included dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number: EK9231, Expiration Date: not reported), via an unspecified route of administration in left arm on 19Dec2020 09:30 for COVID-19 immunization and experienced sore arm (injection site pain). Medical history included mild Hypothyroidism. Concomitant medication(s) (in two weeks) included ibuprofen (ADVIL [IBUPROFEN]) taken for an unspecified indication, start and stop date were not reported. Patient did not receive any other vaccine in four Patient had no known allergies. weeks. The patient experienced sore arm (injection site pain), headache, low-grade fever, severe joint pain on 10Jan2021. Patient had no covid prior vaccination and was covid tested post vaccination. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 01Dec2020 and 23Dec2020. Therapeutic measures were taken as a result of events with 1000 mg acetaminophen on 10Jan2021 at 6:00 AM. The severe joint pain was lasted 24 hours and recovered on 11Jan2021 and outcome of rest of the events was recovered on an unspecified date.   No follow-up attempts are possible; No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021239769 same patient/drug, different dose/event
Information has been received through the Merck Pregnancy Registry concerning a 31 year old female with an allergy to penicillin and a history of pulmonary embolism who on 20-JUL-2007 was vaccinated with varicella virus vaccine live (Oka/Merck). On 20 JUL 2007 the patient reported experiencing pain at the injection site after receiving her vaccination with varicella virus vaccine live (Oka/Merck). The pain resolved, and the patient was recovered on 24 JUL 2007. Concomitant therapy included warfarin sodium (COUMADIN). The lot number was not available. On 02 AUG 2007 the patient was tested and discovered she was pregnant. Unspecified medical attention was sought. There was no product quality complaint.  This in follow-up to report(s) previously reported on 5/16/2008. On 08-JUN-2009, attempts to obtain follow-up information have been unsuccessful. Follow-up information has been received from the physician that the 31 year old female patient and delivered a normal infant without congenital anomaly. Additional information has been requested.
itchiness at the injection site; hardness at the injection site; rash underneath the injection site (4 inches long and 2 inches wide); swollen at injection site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 19-Feb-2021 and was forwarded to Moderna on 19-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchiness at the injection site), VACCINATION SITE INDURATION (hardness at the injection site), VACCINATION SITE RASH (rash underneath the injection site (4 inches long and 2 inches wide)) and VACCINATION SITE SWELLING (swollen at injection site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 003A21A) for COVID-19 vaccination.     No medical history was provided.  Concurrent medical conditions included Iodine allergy.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itchiness at the injection site), VACCINATION SITE INDURATION (hardness at the injection site), VACCINATION SITE RASH (rash underneath the injection site (4 inches long and 2 inches wide)) and VACCINATION SITE SWELLING (swollen at injection site). On 26-Feb-2021, VACCINATION SITE PRURITUS (itchiness at the injection site), VACCINATION SITE INDURATION (hardness at the injection site), VACCINATION SITE RASH (rash underneath the injection site (4 inches long and 2 inches wide)) and VACCINATION SITE SWELLING (swollen at injection site) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment: supplements, fish oil, vitamins, COQ10 and vitamin D   This case was linked to MOD-2021-097393 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: completed Moderna VAER form
Within 3 hours of receiving vaccine, pt. started experiencing flu-like symptoms, headache, body ache, fever and slightly blurred vision.  He is still in bed with the same symptoms.  We are treating with Tylenol, 2 every 4-6 hours.
No additional adverse event; Rotateq that underwent high and low temperature excursions was administered; This spontaneous report was received from a medical assistance referring to a patient of unknown age and gender. The patient's concurrent conditions, pertinent medical history, concomitant medications, drug reactions or allergies were no reported.   On 22-FEB-2022, the patient was vaccinated with improperly stored rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (Lot# 1741381and expiration date 04-SEP-2022) (exact dose and frequency were not reported) as prophylaxis. (product storage error). The vaccine underwent a high and low temperature excursion below 36 Fahrenheit (35.4 Fahrenheit) for 0 hours 12 minutes and 0 seconds. Previous temperature excursion was above 47 Fahrenheit (51.4 Fahrenheit) for 1 hours 6 minutes and 0 seconds. No additional adverse event reported, no further information provided.
Approximately 10 minutes after injection patient's face became flushed, she then complained of being very tired. Patient acting lethargic. Patient after juice and laying down unable to keep awake .
Eye blood vessel been shot/Red eye; tired; migraine; sharp pain; fever; stabbing pain on the left side of her skull; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), HEADACHE (stabbing pain on the left side of her skull), FATIGUE (tired), MIGRAINE (migraine) and PAIN (sharp pain) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced PYREXIA (fever), HEADACHE (stabbing pain on the left side of her skull) and PAIN (sharp pain). On 01-Apr-2021, the patient experienced FATIGUE (tired) and MIGRAINE (migraine). On 25-Apr-2021, the patient experienced OCULAR HYPERAEMIA (Eye blood vessel been shot/Red eye). On 01-Apr-2021, PYREXIA (fever), HEADACHE (stabbing pain on the left side of her skull) and PAIN (sharp pain) had resolved. At the time of the report, FATIGUE (tired), MIGRAINE (migraine) and OCULAR HYPERAEMIA (Eye blood vessel been shot/Red eye) outcome was unknown.            Concomitant medication history not provided.Treatment information provided by reporter included Tylenol.
Patient's wife stated 4 hours after receiving the vaccine he had tremors, sweating, and weakness. Went to ER and was told it might have been from the flu shot. Not sure what he was given at hospital.
Extreme fussiness. Refused to bear weight. Seemed disoriented to parents 48 hours after vaccine. No fevers, positive cold like symptoms-on medication.
Seizure activity x 2 @ 6AM upon waking. Slept x 4 hours : fine now. Seizure medication level pending.  Nurse follow up on 10/30/04 states: "There are no new information."
PROQUAD was inadvertently administered instead of the intended MMR II; VARIVAX was also adminstered along with the PROQUAD; No adverse affects reported; This spontaneous report was received from a licensed practical nurse referring to a patient of an unknown age and gender. No information was provided regarding the patient's medical history, current conditions, concomitant medications, drug reactions and allergies.  On an unknown date, the patient was inadvertently administered a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA)(PROQUAD) subcutaneously, with lot number R021101 and expiration date 20-JAN-2020, for prophylaxis  (dose, dose number and anatomical injection site were not reported), instead of intended measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) for prophylaxis (dose, dose number, route of administration, anatomical injection site, lot number and expiration date)(wrong product administered). It was also reported that varicella virus vaccine live (Oka/Merck) (VARIVAX) for prophylaxis (dose, dose number, anatomical injection site, route of administration, lot number and expiration date were not reported) was also administered along with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA)(PROQUAD) (inappropriate schedule of vaccine administered). No adverse effects reported.
Patient has significant pain in (R) deltoid. She reports pneumonia vaccine and ZOSTAVAX were given there Sept 28, 2012 at health center.
Received Pfizer Bivalent dose on 09/13/2023 - No adverse advent experienced.